Figure 1From: The prognostic value of the suPARnostic®ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphismsThe uPAR promoter from -644 bp to +160 relative to the transcription start site with known regulatory sites and the two identified transitions.Back to article page